(July 20, 2018, 8:57 AM EDT) -- WASHINGTON, D.C. — Medical device maker AngioDynamics Inc. has agreed to pay $12.5 million to resolve whistle-blower allegations that it marketed two devices for off-label uses and caused the submission of false claims to Medicare, Medicaid and other federal health care programs, the U.S. Justice Department announced in a July 19 press release (United States, et al., ex rel. Ryan Bliss v. Biocompatibles, Inc., et al., No. SA-13-CA-0667, W.D. N.Y.)....